Advertisement

Index by Author

February 1984; 33 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aguayo, J

    • Direct measurement of polyol pathway activity in the ocular lens. Diabetes February 1984 33:196-199; doi:10.2337/diabetes.33.2.196

  2. Asayama, K

    • Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes February 1984 33:160-163; doi:10.2337/diabetes.33.2.160

  3. Assan, R

    • Anti-beta-cell immunity in insulinopenic diabetic dogs. Diabetes February 1984 33:135-140; doi:10.2337/diabetes.33.2.135

B

  1. Barnett, P

    • Direct measurement of polyol pathway activity in the ocular lens. Diabetes February 1984 33:196-199; doi:10.2337/diabetes.33.2.196

  2. Bell, G I

    • A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes February 1984 33:176-183; doi:10.2337/diabetes.33.2.176
    • The human glucagon gene is located on chromosome 2. Diabetes February 1984 33:200-202; doi:10.2337/diabetes.33.2.200

  3. Berrie, M A

    • A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes February 1984 33:141-152; doi:10.2337/diabetes.33.2.141

  4. Blue, M L

    • Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions. Diabetes February 1984 33:105-110; doi:10.2337/diabetes.33.2.105

  5. Bonner-Weir, S

    • Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes February 1984 33:170-175; doi:10.2337/diabetes.33.2.170

  6. Burr, I M

    • Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes February 1984 33:160-163; doi:10.2337/diabetes.33.2.160

C

  1. Cheng, H M

    • Direct measurement of polyol pathway activity in the ocular lens. Diabetes February 1984 33:196-199; doi:10.2337/diabetes.33.2.196

  2. Chylack, L T, Jr

    • Direct measurement of polyol pathway activity in the ocular lens. Diabetes February 1984 33:196-199; doi:10.2337/diabetes.33.2.196

D

  1. Debray-Sachs, M

    • Anti-beta-cell immunity in insulinopenic diabetic dogs. Diabetes February 1984 33:135-140; doi:10.2337/diabetes.33.2.135

  2. Dodds, W J

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

E

  1. English, D

    • Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes February 1984 33:160-163; doi:10.2337/diabetes.33.2.160

  2. Estensen, R D

    • Concanavalin A and alloxan interactions on glucose-induced insulin secretion and biosynthesis from islets of Langerhans. Diabetes February 1984 33:164-169; doi:10.2337/diabetes.33.2.164

F

  1. Fletcher, D J

    • Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes February 1984 33:170-175; doi:10.2337/diabetes.33.2.170

  2. Foster, D W

    • Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding. Diabetes February 1984 33:192-195; doi:10.2337/diabetes.33.2.192

  3. Frank, B H

    • In vitro characterization of biosynthetic human proinsulin. Diabetes February 1984 33:111-118; doi:10.2337/diabetes.33.2.111

  4. Fujimoto, W

    • Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid. Diabetes February 1984 33:119-124; doi:10.2337/diabetes.33.2.119

G

  1. Gepts, W

    • Anti-beta-cell immunity in insulinopenic diabetic dogs. Diabetes February 1984 33:135-140; doi:10.2337/diabetes.33.2.135

  2. Gerich, J

    • Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes February 1984 33:184-191

  3. González, R G

    • Direct measurement of polyol pathway activity in the ocular lens. Diabetes February 1984 33:196-199; doi:10.2337/diabetes.33.2.196

  4. Goodman, A D

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

  5. Goodner, C J

    • A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes February 1984 33:141-152; doi:10.2337/diabetes.33.2.141
    • Insulin dose-response characteristics among individual muscle and adipose tissues measured in the rat in vivo with 3[H]2-deoxyglucose. Diabetes February 1984 33:153-159; doi:10.2337/diabetes.33.2.153

  6. Gottesman, I

    • Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes February 1984 33:184-191

H

  1. Hom, F G

    • A [3H]2-deoxyglucose method for comparing rates of glucose metabolism and insulin responses among rat tissues in vivo. Validation of the model and the absence of an insulin effect on brain. Diabetes February 1984 33:141-152; doi:10.2337/diabetes.33.2.141
    • Insulin dose-response characteristics among individual muscle and adipose tissues measured in the rat in vivo with 3[H]2-deoxyglucose. Diabetes February 1984 33:153-159; doi:10.2337/diabetes.33.2.153

  2. Horita, S

    • A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes February 1984 33:176-183; doi:10.2337/diabetes.33.2.176

J

  1. Jondet, A

    • Anti-beta-cell immunity in insulinopenic diabetic dogs. Diabetes February 1984 33:135-140; doi:10.2337/diabetes.33.2.135

K

  1. Karam, J H

    • A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes February 1984 33:176-183; doi:10.2337/diabetes.33.2.176

  2. Kassoff, A

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

L

  1. Lamberton, R P

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

M

  1. Mandarino, L

    • Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes February 1984 33:184-191

  2. May, J M

    • Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes February 1984 33:170-175; doi:10.2337/diabetes.33.2.170

  3. McGarry, J D

    • Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding. Diabetes February 1984 33:192-195; doi:10.2337/diabetes.33.2.192

  4. Merimee, T J

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

  5. Metz, S A

    • Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid. Diabetes February 1984 33:119-124; doi:10.2337/diabetes.33.2.119

  6. Murphy, R C

    • Effects on glucose-induced insulin secretion of lipoxygenase-derived metabolites of arachidonic acid. Diabetes February 1984 33:119-124; doi:10.2337/diabetes.33.2.119

N

  1. Newgard, C B

    • Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding. Diabetes February 1984 33:192-195; doi:10.2337/diabetes.33.2.192

O

  1. Olefsky, J M

    • In vitro characterization of biosynthetic human proinsulin. Diabetes February 1984 33:111-118; doi:10.2337/diabetes.33.2.111

P

  1. Podlecki, D A

    • In vitro characterization of biosynthetic human proinsulin. Diabetes February 1984 33:111-118; doi:10.2337/diabetes.33.2.111

R

  1. Rubin, C L

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

S

  1. Saba, T M

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

  2. Sai, P

    • Anti-beta-cell immunity in insulinopenic diabetic dogs. Diabetes February 1984 33:135-140; doi:10.2337/diabetes.33.2.135

  3. Shin, S I

    • Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions. Diabetes February 1984 33:105-110; doi:10.2337/diabetes.33.2.105

  4. Shows, T B

    • The human glucagon gene is located on chromosome 2. Diabetes February 1984 33:200-202; doi:10.2337/diabetes.33.2.200

  5. Slonim, A E

    • Chemiluminescence as an index of drug-induced free radical production in pancreatic islets. Diabetes February 1984 33:160-163; doi:10.2337/diabetes.33.2.160

  6. Steffes, M W

    • Concanavalin A and alloxan interactions on glucose-induced insulin secretion and biosynthesis from islets of Langerhans. Diabetes February 1984 33:164-169; doi:10.2337/diabetes.33.2.164

  7. Steinbrecher, U P

    • Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes February 1984 33:130-134; doi:10.2337/diabetes.33.2.130

T

  1. Treble, D H

    • Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes February 1984 33:125-129; doi:10.2337/diabetes.33.2.125

  2. Trent, D F

    • Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes February 1984 33:170-175; doi:10.2337/diabetes.33.2.170

  3. Tricoli, J V

    • The human glucagon gene is located on chromosome 2. Diabetes February 1984 33:200-202; doi:10.2337/diabetes.33.2.200

V

  1. Virji, M A

    • Concanavalin A and alloxan interactions on glucose-induced insulin secretion and biosynthesis from islets of Langerhans. Diabetes February 1984 33:164-169; doi:10.2337/diabetes.33.2.164

W

  1. Weir, G C

    • Abnormal islet and adipocyte function in young B-cell-deficient rats with near-normoglycemia. Diabetes February 1984 33:170-175; doi:10.2337/diabetes.33.2.170

  2. Witztum, J L

    • Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes February 1984 33:130-134; doi:10.2337/diabetes.33.2.130

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement